Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Harmony Biosciences Holdings, Inc.

NASDAQ: HRMY · Life Sciences · 5 alerts · CIK 1802665

Share price
$32.96Close, Nov 16
Market cap
$1.94B
Shares outstanding
58.72MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Harmony Biosciences Holdings, Inc. filings on SEC EDGAR ↗

4:15 PM ET 8-K/A
Executive Compensation

Harmony Biosciences Holdings Executive Compensation

Harmony Biosciences announced the compensation terms for its leadership succession plan, including a separation and consulting agreement for retiring CEO Jeffrey M. Dayno and an amended employment agreement for incoming CEO Peter Anastasiou. Dr. Dayno will serve as a non-executive advisor through January 2028 at a rate of $500 per hour with continued equity vesting, while Mr. Anastasiou's new terms as President and CEO take effect January 1, 2027.

Term
through Jan 2028

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.